News
Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...
A nurse-led intervention had a greater effect on dyspnea among patients with advanced lung cancer who experienced improvement in their psychological distress.
Cancer operations that remove whole or parts of an organ can be life-altering. New research suggests that some patients may ...
Preventing this complication for those who receive a lung transplant is of the highest priority, as there ... Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent ...
"Lung cancer is notoriously awful because when it is found, a lot of the time it is Stage 3 and 4, which is hard to treat, ...
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC
Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...
Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...
“Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer,” said ... The standard of care for second-line treatment is also evolving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results